deltatrials
Completed NCT00715468

Prospective, 6 Month, Open Label, Conversion Study From Mycophenolate Mofetil (MMF) to PRMYFORTIC*

Prospective, 6 Month, Open Label, Conversion Study From MMF to MYFORTIC* Evaluating the Severity of GI Symptoms and MPA Metabolite as a Surrogate Marker of MYFORTIC

Sponsor: Maisonneuve-Rosemont Hospital

Conditions Late Complication From Kidney Transplant
Updated 7 times since 2017 Last updated: Dec 11, 2014 Started: Aug 31, 2007 Primary completion: Dec 31, 2013 Completion: Apr 30, 2014

A observational or N/A phase clinical study on Late Complication From Kidney Transplant, this trial is completed. The trial is conducted by Maisonneuve-Rosemont Hospital and has accumulated 7 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2021 — Jul 2024 [monthly]

    Completed

  5. Jun 2018 — Jan 2021 [monthly]

    Completed

▶ Show 2 earlier versions

  1. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

  2. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Maisonneuve-Rosemont Hospital
  • Novartis
Data source: Maisonneuve-Rosemont Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Montreal, Canada